NASDAQ:KZR
Kezar Life Sciences, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.kezarlifesciences.comipo date
Jun 21, 2018
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, inclu...Show More
Earnings
Earnings Release in 12 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus